VTRS - candlestick chart analysis of Viatris Inc.

Popular stocks today

AAPL APH AVGO CELH EQNR GME HPE INTC LVS MCD MU NUGT NVDA OKE QQQ SEDG SMCI SPY TSLA VOO

Membership
- Log In
- Log Out
- Sign Up
- About HotCandlestick
- Benefits
- Help
Candlestick Charts
Chart Education
Trading Tools
Opportunities
External Links

Official PayPal Seal

As Seen In...

The Complete Guide to Using Candlestick Charting: How to Earn High Rates of Return safely

VTRS Earnings: *Thu 06-FEB-2025

End of day quotes updated Fri Dec 6 15:46 CST
🏠

⎙

🔍

◄ Daily Pattern ► ◄ Weekly Pattern ► ◄ Monthly Pattern ► ◄ Quarterly Pattern ►
Bearish Harami Bearish Engulfing Bearish Three Outside Down Bearish Three Outside Down
08-Nov-2024 05-Jul-2024 31-Oct-2023 30-Jun-2022
2.9 strength -87.8 strength -20.3 strength -306.6 strength

VTRS	SPY
-1.3 -2.8 -2.8 9.6 21.1	0.2 0.9 0.9 5.9 28.7
% Price Gain WTD Performance (%) MTD Performance (%) QTD Performance (%) YTD Performance (%)
SPY tracks S&P 500 index.

VTRS News
6-Dec-2024 7:02 AM CST - Business Insider Viatris price target raised to $14 from $13 at Piper Sandler Piper Sandler raised the firm's price target on Viatris (VTRS) to $14 from $13 and keeps a Neutral rating on the shares following the firm's
6-Dec-2024 6:23 AM CST - Business Insider Piper Sandler Sticks to Its Hold Rating for Viatris (VTRS) In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Viatris (VTRS - Research Report), with a price target
8-Nov-2024 2:43 PM CST - Business Insider Viatris price target raised to $12 from $11 at Barclays Barclays analyst Balaji Prasad raised the firm's price target on Viatris (VTRS) to $12 from $11 and keeps an Underweight rating on the
8-Nov-2024 8:16 AM CST - MSN Viatris Inc. (NASDAQ:VTRS) Q3 2024 Earnings Call Transcript Q3 2024 Earnings Call Transcript November 7, 2024 Operator: Good morning, everyone, and welcome to the Viatris Q3 2024 Earnings Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation,
8-Nov-2024 5:26 AM CST - Business Insider Viatris Inc. Reports Strong Q3 2024 Performance Viatris, Inc. ( (VTRS)) has released its Q3 earnings. Here is a breakdown of the information Viatris, Inc. presented to its investors. Viatris Inc. is a global healthcare company engaged in providing access to high-quality medicines and bridging the gap ...
8-Nov-2024 1:21 AM CST - Yahoo Finance Viatris Inc (VTRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ... Viatris Inc (VTRS) reports solid financial performance with a focus on innovation and debt management, despite challenges in certain markets.
7-Nov-2024 9:37 PM CST - Business Insider Viatris Underperform Rating: Limited Growth Prospects and Conservative Capital Allocation Strategy Gerberry sees limited upside potential for Viatris's stock, justifying the Underperform rating. In another report released on November 6, Barclays also assigned a Sell rating to the stock with a $11.00 price target. VTRS's price has also changed ...
7-Nov-2024 4:19 PM CST - Morningstar Viatris to Benefit From an Optimized Business, Strategic Business Deals, and a Developing Pipeline A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in adequate financial health.
7-Nov-2024 12:54 PM CST - The Motley Fool Viatris Tops Analyst Estimates in Q3 Pharmaceutical company Viatris (VTRS 13.52%) reported third-quarter 2024 financial results on Thursday, Nov. 7, that topped analyst estimates. Revenue for the quarter hit $3.8 bil

Disclaimer Privacy Contact

Copyright © 2001-2024, All rights reserved.
HotCandlestick.com, LLC

VTRS News
6-Dec-2024 7:02 AM CST - Business Insider Viatris price target raised to $14 from $13 at Piper Sandler Piper Sandler raised the firm's price target on Viatris (VTRS) to $14 from $13 and keeps a Neutral rating on the shares following the firm's
6-Dec-2024 6:23 AM CST - Business Insider Piper Sandler Sticks to Its Hold Rating for Viatris (VTRS) In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Viatris (VTRS - Research Report), with a price target
8-Nov-2024 2:43 PM CST - Business Insider Viatris price target raised to $12 from $11 at Barclays Barclays analyst Balaji Prasad raised the firm's price target on Viatris (VTRS) to $12 from $11 and keeps an Underweight rating on the
8-Nov-2024 8:16 AM CST - MSN Viatris Inc. (NASDAQ:VTRS) Q3 2024 Earnings Call Transcript Q3 2024 Earnings Call Transcript November 7, 2024 Operator: Good morning, everyone, and welcome to the Viatris Q3 2024 Earnings Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation,
8-Nov-2024 5:26 AM CST - Business Insider Viatris Inc. Reports Strong Q3 2024 Performance Viatris, Inc. ( (VTRS)) has released its Q3 earnings. Here is a breakdown of the information Viatris, Inc. presented to its investors. Viatris Inc. is a global healthcare company engaged in providing access to high-quality medicines and bridging the gap ...
8-Nov-2024 1:21 AM CST - Yahoo Finance Viatris Inc (VTRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ... Viatris Inc (VTRS) reports solid financial performance with a focus on innovation and debt management, despite challenges in certain markets.
7-Nov-2024 9:37 PM CST - Business Insider Viatris Underperform Rating: Limited Growth Prospects and Conservative Capital Allocation Strategy Gerberry sees limited upside potential for Viatris's stock, justifying the Underperform rating. In another report released on November 6, Barclays also assigned a Sell rating to the stock with a $11.00 price target. VTRS's price has also changed ...
7-Nov-2024 4:19 PM CST - Morningstar Viatris to Benefit From an Optimized Business, Strategic Business Deals, and a Developing Pipeline A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in adequate financial health.
7-Nov-2024 12:54 PM CST - The Motley Fool Viatris Tops Analyst Estimates in Q3 Pharmaceutical company Viatris (VTRS 13.52%) reported third-quarter 2024 financial results on Thursday, Nov. 7, that topped analyst estimates. Revenue for the quarter hit $3.8 bil